Should Clinical Product Managers Be CSO-Trained?
It's a question I get asked a lot and the answer isn't as obvious as you might think
This is Clinical Product Thinking 🧠, a weekly newsletter featuring practical tips, frameworks and strategies from the frontlines of clinical product.
Welcome, friends, this is issue No. 030 of Clinical Product Thinking. This week we’re diving into a question I hear a lot: should clinical product managers be clinical safety trained? Let’s talk about it.
At its simplest, clinical safety is about ensuring that the products we build, digital health apps, medical devices, AI tools, prescribing services and care pathways do not cause harm when they are used in the real world. That is with real patients, messy workflows, incomplete data and clinicians who are already under pressure.
In the UK, clinical safety officers (CSOs) are responsible for ensuring that health technology systems are safe to use and that risks are identified, assessed and managed across the lifecycle of a product or service.
That includes understanding regulatory frameworks, running formal risk assessments, documenting hazards, reviewing incidents and making sure organisations meet relevant standards such as DCB0129 / DCB0160.
What CSO Training Actually Covers
Formal CSO training is not about learning how to write documents. It’s about learning how to think about risk in a structured way.
Most training covers some combination of:
Risk identification and hazard analysis: How to systematically ask: what could go wrong, how likely is it and what would the impact be?
Risk mitigation: How to design controls that reduce the likelihood or severity of harm
Regulatory and safety standards: Understanding frameworks like ISO 14971, DCB0129 and DCB0160.
Clinical risk assessment and documentation: Writing safety cases, hazard logs and risk assessments that stand up to scrutiny.
Post-market surveillance and incident review: What happens after launch, when real users do things you didn’t expect.
Patient safety principles: Designing systems that are safe not just when used correctly, but when used imperfectly.
None of this is theoretical. It is an essential part of building safe and effective digital health.
Should Clinical Product Managers Be Safety Trained?
My view is yes, Clinical Product Managers (CPMs) should be CSO-trained and here’s why:
Safety problems start in product decisions, not in safety reviews
If you’ve ever worked on a clinical product, you’ve seen examples like this first-hand:
A prescribing flow that works perfectly in staging but fails when a patient misunderstands a question.
A speech-to-text algorithm that performs well in validation but behaves unpredictably in a noisy A&E.
An alert system that flags the right events in testing but generates so much noise in production that clinicians start ignoring it
CSO training helps CPMs see these risks sooner, when they are still cheap to fix.
Regulation is part of the product, not something bolted on later
Regulation is a design constraint, not a post-build action. When you’re building healthtech, you need to know:
what standard applies
what needs documenting
what needs sign-off
what will get questioned later
If people in the product team don’t understand this, you get the classic pattern:
Build → launch → panic → retrofit → slow everything down.
When CPMs understand safety frameworks, they design with those constraints in mind instead of discovering them at the worst possible moment.
It makes cross-functional work much easier
Clinical products sit in the middle of a lot of worlds:
clinicians
engineers
compliance
safety
commercial
regulators
And those groups do not naturally speak the same language.
A CPM with clinical safety knowledge can translate between them, turning risk into product decisions, regulation into requirements, and incidents into design changes.
That reduces friction across the whole team, and friction is usually what slows you down.
Risk management is already part of the CPM skillset
Clinical safety is structured thinking about failure modes.
What happens if the user clicks the wrong thing?
What happens if the data is missing?
What happens if the workflow is used differently than expected?
Good CPMs tend to think this way already, but CSO training makes that thinking explicit and systematic. You start designing with the assumption that the real world will not behave exactly as the spec says it should, and that mindset tends to produce products that are both safer and more usable.
In summary, the relatively modest time and monetary investment (more on this below) is well worth it. I’d also add that I consider clinical safety principles every single day.
The Case Against CSO Training
It is worth making an important distinction here. Completing CSO training as a CPM does not mean you should formally take on the CSO role. My personal view is that most CPMs working on clinical products would benefit from safety training, but only a small minority should hold formal CSO responsibility. We will look at clinical product and clinical safety team structures in a later post.
You’re more likely to be asked to take on the role
In startups, as a CPM with CSO training, there is a real chance you will asked to take on the CSO role, often with only a small amount of your time reserved for the task e.g. 10%.
This can work for earlier-stage, lower-risk products but it can also create risk for the individual as well as the organisation. Clinical safety is a formal responsibility, and it is difficult to do properly as a side task.
Role overlap and specialisation
Clinical safety is a highly specialised field. While having familiarity with safety standards is beneficial, CPMs need to focus on the broader scope of product development. The time invested in CSO training might distract from the core responsibilities of a CPM.
Role boundaries can become unclear
In many organisations, clinical safety sits with a dedicated CSO or safety function. If CPMs are also CSO trained the risk is that role boundaries become unclear.
You can end up with decisions sitting in the middle, where clinical product thinks safety owns the risk, safety thinks clinical product owns the design, and nobody is quite sure who is accountable for the final call. Organisations still need clear ownership of safety decisions.
Risk of over-engineering
CPMs who are newly exposed to safety frameworks can sometimes feel pressure to design for every possible risk scenario, which can slow development or introduce unnecessary complexity.
Safety matters, but so does usability, speed and the ability to iterate. Balancing those pressures is part of the job.
So, Should CPMs Be CSO-Trained?
My view is yes. Anyone working as a Clinical Product Manager on clinical products should understand clinical safety principles, and formal training is a worthwhile investment. Increasingly, job descriptions are also starting to ask for it.
Taking on the CSO role, however, will only make sense for some people, in some organisations, at some stages.
Clinical Safety Training Courses
Most people in the UK complete the NHS England Clinical Safety training. This usually involves basic and intermediate self-paced online modules, followed by a one-day practitioner course, which can be taken remotely or in person.
If you are currently working within the NHS the online courses are typically free. For practitioner training the cost ranges from £475 - £625. They also sell out quite quickly so do book ahead!
Another well-regarded option is the clinical safety course run by DPM. I haven’t taken this one myself, but several peers in the industry have told me it’s a longer, slightly more in-depth, manufacturer-focused course.
(This is not sponsored, just sharing options people commonly take.)
Join Us at HLTH Europe 🇪🇺
Danielle Brightman and I are running a panel event on clinical product with two incredible guest speakers. If you don’t know about HLTH, it’s the health tech conference you absolutely cannot miss.
👉 Register your interest for the panel here.
🎟️ Get your HLTH ticket here. (Use code: HE26PP_CPT250 for €250 off your ticket!)
Clinical Product Drinks ✨
📆 25th March, 6:30pm, The Folly.
Join for a drink with other folks at the front line of clinical product. This is an informal evening to mingle and share experiences. No agenda, no panel or slides. 👉 More tickets released here.
That’s all for this week. See you next time! 👋
🤝 Work with me | 📅 Attend an event | | ✍️ Send a message
Written by Dr.Louise Rix, Head of Clinical Product, doctor and ex-VC. Passionate about all things healthcare, healthtech and clinical product (…obviously). Based in London. You can find me on Linkedin.
Made with 💜 for better, safer HealthTech.